Abraxis BioScience Inc. · Los Angeles, CA United States · (NASDAQ (GS): ABII)

More Companies in: Los Angeles, California

More Companies in These Related Industries: Pharmaceutical Preparation Mfg

Cancer patients will hopefully get a helpful shot in the arm thanks to Abraxis BioScience. The company's oncology and research division is developing a line of injectable drugs starting with Abraxane, its patented version of cancer drug paclitaxel that is approved to treat breast cancer. Abraxis BioScience is working to commercialize Abraxane; The drug is approved for marketing in about 35 countries and available in nine; the company is working to get it on the market in others. It often works with local partners to sell the drug in global markets. Abraxis owns manufacturing and development facilities in the US, Puerto Rico, and Switzerland. Chairman and CEO Patrick Soon-Shiong holds more than 80% of the company. To read the full description, subscribe now.